The Australasian College of Cutaneous Oncology provides training and education to improve and certify competency in the management of skin cancer. Our policy is that no pharmaceutical company shall be permitted to sponsor or endorse any event, function or workshop in any manner. This creates a truly unique and unbiased learning environment.
July 2015 ACCO news update here
American Mohs Surgery Trial here
allmedic.org.au - Info on our Allmedic research here
The ACCO Mission
1) Workshops of quality for doctors & nurses
2) Examine competence in managing skin cancer
3) Convene biennial skin cancer conference
4) Donate all proceeds over costs to medical research and education
5) All with the highest standards of impartiality
ACCO Certifications Pathway
• Diploma in Skin Cancer Surgery (DACCO)
• Advanced Diploma is skin cancer surgery
ACCO research programs are ongoing. In 2015, ACCO's first published research is our manuscript details the post procedural pain of PDT compared with surgery. This comparison found that patient's experienced considerably more pain following face PDT than major face surgical procedures. The research was published in the February Edition of Journal Of Plastic Reconstructive and Aesthetic Surgery. The abstract can be found here.
In April 2014 ACCO published our randomized controlled trial in Dermatologic Surgery regarding whether PDT to the face of those who have suffered skin cancer would prevent further skin cancers. We found there was no preventative advantage to PDT. The abstract can be found here. ACCO comments on the lack of regulatory approval of Australia placing Australians at risk of dangerous skin treatments.
In 2014 a related manuscript detailing the adverse events of non TGA approved PDT was published in Journal of Drugs in Dermatology. The abstract can be found here.
© ACCO All rights
retained - Founded in Victoria in 2006